Our board members have graciously agreed to advise the UNITED consortium through their complimentary experience and expertise within neurodegenerative diseases, neuroimaging, genetics, epidemiology and consortium initiatives.

The chair of the UNITED consortium scientific advisory board, Dr. Albert Hofman, is the chair of the Department of Epidemiology and a Professor of Public Health and Clinical Epidemiology at the T.H Chan School of Public Health, Harvard. Dr. Hofman has vast experience in leading global consortia such as the Alzheimer Cohorts Consortium.

Also based within the United States Dr. Sudha Seshadri, and Professor Michael Weiner will providing invaluable advice based on their experience in neurodegenerative disease consortia and initiatives. Dr. Seshadri, founding director of Glenn Biggs Institute for Alzheimer’s and Neurodegeneration and senior investigator of The Framingham Heart Study, also has exceptional leadership in global consortia including CHARGE. Additionally, Professor Weiner, of University of California, San Francisco, is the coordinator of the Alzheimer’s Disease Neuroimaging Initiative, an initiative unparalleled in its impact on the field.

Within South America, Dr Agustin Ibáñez, will be advising us not only through extensive knowledge in neuroscience and dementia but also through his experience in in creating a platform for collaboration on dementia research within South America as the coordinator of the Latin America and Caribbean Consortium on Dementia (LAC-CD).

We will also be joined by Professor Louis Tan Chew Seng, who is based in Singapore. Professor Seng has considerable expertise in leading multicenter studies on Parkinson’s disease within Asia and is a co-director of the Parkinson’s Disease and Movement Disorders Centre.

Furthermore, Professor Jonathon Rohrer will be providing valuable guidance and expertise on genetics, dementia, and consortia initiatives due to his involvement in coordinating global FTD consortia, including the multicenter GENFI. Professor Rohrer is based in UCL Queen square Institute of Neurology in London, UK.